Effects of sodium restriction and cyclooxygenase-2 inhibition on the course of hypertension, proteinuria and cardiac hypertrophy in Ren-2 transgenic rats

Physiological Research

Volumn 54, Issue 1, 2005, Pages 17-24

  Vaněčková, Ivana ^a   Skaroupkova P ^a   Dvorak P ^a   Certikova Chabova V ^b   Tesar V ^b   Bader, M ^c   Ganten, D ^c   Kramer, H J ^d  

^a INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

^c MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^d UNIVERSITY OF BONN   (Germany)

Author keywords

Cyclooxygenase 2; Hypertension; Low sodium diet; Ren 2 transgenic rats

Indexed keywords

ANGIOTENSIN; CYCLOOXYGENASE 2; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; PROSTAGLANDIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; DISEASE COURSE; ENZYME INHIBITION; GENE; HEART VENTRICLE HYPERTROPHY; HYPERTENSION; MALE; NONHUMAN; PATHOPHYSIOLOGY; PLETHYSMOGRAPHY; PROTEINURIA; RAT; REN 2 GENE; SODIUM RESTRICTION; SYSTOLIC BLOOD PRESSURE; TRANSGENIC ANIMAL; VASODILATATION;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; BLOOD PRESSURE; BODY WEIGHT; CARDIOMEGALY; CYCLOOXYGENASE INHIBITORS; HYPERTENSION, RENAL; MALE; NITROBENZENES; ORGAN SIZE; PROTEINURIA; RATS; RATS, SPRAGUE-DAWLEY; RENIN; SODIUM CHLORIDE, DIETARY; SULFONAMIDES;

EID: 14944344225     PISSN: 08628408     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. BARRETT GL, MULLINS JJ: Studies on blood pressure regulation in hypertensive ren-2 transgenic rats. Kidney Int 41 (Suppl 37): S125-S128, 1992.
2. BEIERWALTES WH: Cyclooxygenase-2 products compensate for inhibition of nitric oxide regulation of renal perfusion. Am J Physiol 283: F68-F72, 2002.
3. BÖHM M, LEE MA, KREUTZ MA, KIM S, SCHNINKE M, DJAVIDANI B, WAGNER J, KALING M, WIENEN W, BADER M, GANTEN D: Angiotensin II receptor blockade in TGR(mRen2)27: effects on renin-angiotensin-system gene expression and cardiovascular functions. J Hypertens 13: 891-899, 1995.
4. CALLAHAN MF, LI P, FERRARIO CM, GANTEN D, MORRIS M: Salt-sensitive hypertension in (mREN-2)27 transgenic rats. Hypertension 27: 573-577, 1996.
5. CHENG HF, HARRIS RC: Cyclooxygenases, the kidney, and hypertension. Hypertension 43: 1-6, 2004.
6. CHENG ZJ, TIKKANEN I, VAPAATALO H, MERVAALA EMA: Vascular effects of COX inhibition and AT, receptor blockade in transgenic rats harboring mouse renin-2 gene. J Physiol Pharmacol 53: 597-613, 2002.
7. CHUNG O, SCHIPS T, ROHMEISS P, GRETZ N, STRAUCH M, UNGER T: Protein excretion and renal adaptation of transgenic mRen2 rats to changing oral sodium loads. J Hypertens 11 (Suppl 5): S188-S189, 1993.
8. GROSS V, LIPPOLDT A, SCHNEIDER W, LUFT FC: Effect of captopril and angiotensin II receptor blockade on pressure natriuresis in transgenic TGR(mRen2)27 rats. Hypertension 26: 471-479, 1995.
9. HARDING P, CARRETERO OA, BEIERWALTES WH: Chronic cyclooxygenase-2 inhibition blunts low sodium-stimulated renin without changing renal haemodynamics. J Hypertens 18: 1107-1113, 2000.
10. HARTNER A, GOPPELT-STRAUBE M, HILGERS KF: Coordinate expression of cyclooxygenase-2 and renin in the rat kidney in renovascular hypertension. Hypertension 31: 201-205, 1998.
11. HARTNER A, CORDASIC N, GOPPELT-STRUEBE M, VEELKEN R, HILGERS KF: Role of macula densa cyclooxygenase-2 in renovascular hypertension. Am J Physiol 284: F498-F502, 2003.
12. HELLER J, HELLEROVÁ S: Long-term effect on blood pressure of early brief treatment by different antihypertensive agents: a study in the Prague hypertensive rat. Kidney Blood Press Res 21: 445-451, 1998.
13. HELLER J, HELLEROVÁ S, DOBEŠOVÁ Z, KUNEŠ J, ZICHA J: The Prague hypertensive rat: a new model of genetic hypertension. Clin Exp Hypertens 15: 807-818, 1993.
14. HÖCHERL K, ENDEMANN D, KAMMERL MC, GROBECKER HF, KURTZ A: Cyclooxygenase-2 inhibition increases blood pressure in rats. Br J Pharmacol 136: 1117-1126, 2002.
15. IMIG JD: Eicosanoid regulation of the renal vasculature. Am J Physiol 279: F965-F981, 2000
16. IYER SN, AVERILL DB, CHAPPELL MC, YAMADA K, ALLRED AJ, FERRARIO CM: Contribution of angiotensin-(1-7) to blood pressure regulation in salt-depleted hypertensive rats. Hypertension 36: 417-422, 2000.
17. JACINTO SM, MULLINS JJ, MITCHELL KD: Enhanced renal vascular responsiveness to angiotensin II in hypertensive ren-2 transgenic rats. Am J Physiol 276: F315-F322, 1999.
18. JENSEN BL, KURTZ A: Differential regulation of renal cyclooxygenase mRNA by dietary salt intake. Kidney Int 52: 1242-1249, 1997.
19. KOMERS R, EPSTEIN M: Cyclooxygenase-2 expression and function in renal pathophysiology. J Hypertens 20 (Suppl 6): S11-S15, 2002.
20. 1 receptor blockade in hypertensive Ren-2 transgenic rats. J Hypertens 22: 819-825, 2004.
21. KRÄMER BK, KAMMERL MC, KÖMHOFF M: Renal cyclooxygenase-2 (COX-2). Physiological, pathophysiologicial, and clinical implications. Kidney Blood Press Res 27: 43-62, 2004.
22. LANGHEINRICH M, LEE MA, BÖHM M, PINTO YM, GANTEN D, PAUL M: The hypertensive Ren-2 transgenic rat TGR(mRen2)27 in hypertension research. Characteristics and functional aspects. Am J Hypertens 9: 506-512, 1996.
23. LEENEN HH, TOAL CB: Dietary sodium restriction and the renin-angiotensin system in young spontaneously hypertensive rats, J Hypertens 7: 57-61, 1989.
24. LEVER AF, HARRAP SB: Essential hypertension: a disorder of growth with origins in childhood? J Hypertens 10: 101-120, 1992.
25. LI P, MORRIS M, FERRARIO CM, BARRETT C, GANTEN D, CALLAHAN MF: Cardiovascular, endocrine, and body fluid-electrolyte responses to salt loading in mRen-2 transgenic rats. Am J Physiol 275: H1130-H1137, 1998.
26. LÓPEZ R, LLINÁS MT, ROIG F, SALAZAR FJ: Role of nitric oxide and cyclooxygenase-2 in regulating the renal hemodynamic response to norepinephrine. Am J Physiol 284: R488-R-493, 2003a.
27. LÓPEZ R, ROIG F, LLINÁS MT, SALAZAR FJ: Role of cyclooxygenase-2 in the control of renal haemodynamics and excretory function. Acta Physiol Scand 177: 429-435, 2003b.
28. MANN B, HARTNER A, JENSEN BL, HILGERS KF, HÖCHERL K, KRÄMER BK, KURTZ A: Acute upregulation of COX-2 by renal artery stenosis. Am J Physiol 280: F119-F125, 2001.
29. MITCHELL KD, MULLINS JJ: ANG II dependence of tubuloglomerular feedback responsiveness in hypertensive ren-2 transgenic rats. Am J Physiol 268: F821-F828, 1995.
30. MITCHELL KD, JACINTO SM, MULLINS JJ: Proximal tubular fluid, kidney, and plasma levels of angiotensin II in hypertensive ren-2 transgenic rats. Am J Physiol 273: F246-F253, 1997.
31. MULLINS JJ, PETERS J, GANTEN D: Fulminant hypertension in transgenic rats harboring the mouse Ren-2 gene. Nature 344: 541-544, 1990.
32. MUSCARÁ MN, VERGNOLLE N, LOVREN F, TRIGGLE CR, ELLIOTT SN, ASFAHA S, WALLACE JL: Selective cyclooxygenase-2 inhibition with celecoxib elevates blood pressure and promotes leukocyte adherence. Br J Pharmacol 129: 1423-1430, 2000.
33. NAVAR LG, ZOU L, VON THUN A, WANG T, IMIG JD, MITHCELL K: Unraveling the mystery of Goldblatt hypertension. News Physiol Sci 13: 170-176, 1998.
34. OKUMURA T, HAYASHI I, IKEZAWA T, YAMANAKA M, TAKATA T, FUJITA Y, SAIGENJI K, YAMASHINA S, MAJIMA M: Cyclooxygenase-2 inhibitors attenuate increased blood pressure in renovascular hypertensive models, but not in deoxycorticosterone- salt hypertension. Hypertens Res 25: 927-938, 2002.
35. OPOČENSKÝ M, DVOŘÁK P, MALÝ J, KRAMER HJ, BÄCKER A, KOPKAN L, VERNEROVÁ Z, TESAŘ V, ZIMA T, BADER M, GANTEN D, JANDA J, VANĚČKOVÁ I: Chronic endothelin receptor blockade reduces end-organ damage independently of blood pressure effects in salt-loaded heterozygous Ren-2 transgenic rats. Physiol Res 53: 581-593, 2004.
36. PURDY KE, ARENDSHORST WJ: Prostaglandins buffer ANG II-mediated increases in cytosolic calcium in preglomerular VSMC. Am J Physiol 277: F850-F858, 1999.
37. RONG P, CAMPBELL DJ, SKINNER SL: Hypertension in the (mRen2)27 rat is not explained by enhanced kinetics of transgenic Ren-2 renin. Hypertension 42: 523-527, 2003.
38. SCHORK NJ, JOKELAINEN P, GRANT EJ, SCHORK MA, WEDER AB: Relationship of growth and blood pressure in inbred rats. Am J Physiol 266: R702-R708, 1994.
39. VANĚČKOVÁ I, CAHOVÁ M, KRAMER HJ, HUSKOVÁ Z, ŠKAROUPKOVÁ P, KOMERS R, BADER M, GANTEN D, ČERVENKA L: Acute effects of cyclooxygenase-2 inhibition on renal function in heterozygous transgenic rats on normal or low sodium intake. Kidney Blood Press Res 27: 203-210, 2004.
40. WILCZYNSKI EA, LEENEN HH: Dietary sodium intake and age in spontaneously hypertensive rats: effects on blood pressure and sympathetic activity. Life Sci 41: 707-15, 1987.
41. WANG JL, CHENG HF, SHAPPELL S, HARRIS RC: Cyclooxygenase-2 inhibition decreases renin content and lowers blood pressure in a model of renovascular hypertension. Hypertension 34: 96-101, 1999.
42. YANG T, SINGH I, PHAM H, SUN D, SMART A, SCHNERMANN JB, BRIGGS JP: Regulation of cyclooxygenase expression in the kidney by dietary salt intake, Am J Physiol 274: F481-489, 1998.
43. ZICHA J, KUNEŠ J: Ontogenetic aspects of hypertension development: analysis in the rat. Physiol Rev 79: 1227-1282, 1999.